Therapeutics against HPV infections and related diseases

• SS 04-01 • Overview > K. Kees MELIEF • SS 04-02 • Strong T cell responses after vaccination with HPV16 long peptides for late stage cervical cancer are associated with prolonged survival See abstract > K. Kees MELIEF • SS 04-03 • Efficacy of a carrageenan-based lubricant gel against HPV infection in women: interim analysis of a double-blind, randomized, placebo-controlled trial See abstract > S. Sindy MAGNAN • SS 04-04 • Demethylating treatment induces a dose-and time-dependent reversal of the malignant phenotype and anti-proliferative effects in two-and three-dimensional HPV tumor models See abstract > E-S. Elena-Sophie PRIGGE • SS 04-05 • CRISPR/Cas9 treatments to eliminate HPV and other persistent viral infections See abstract > B. Bolyn HUBBY • SS 04-06 • Immunogenicity of human papillomavirus (HPV) specific DNA vaccine, INO-3112 (HPV16/HPV18 plasmids +IL-12) in HPV+head and neck squamous cell carcinoma (HNSCCA) See abstract > C. Charu AGGARWAL • SS 04-07 • Development of therapeutic cancer vaccine based on p16INK4a See abstract > K. Katherina URBAN • SS 04-08 • Persistent high-risk (HR) HPV infection and vaginal microbiota) See abstract > F. Francesca CAROZZI